XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income/(Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2021 $ 897,808 $ 109 $ 1,666,887 $ (1,088) $ (768,100)
Beginning balance, shares at Dec. 31, 2021   108,210,318      
Issuance of common stock upon exercise of stock options 883   883    
Issuance of common stock upon exercise of stock options, shares   195,799      
Vesting of restricted stock units, Shares   27,233      
Stock compensation expense 13,455   13,455    
Unrealized loss on investments (8,130)     (8,130)  
Net Income (Loss) (62,046)       (62,046)
Ending balance at Mar. 31, 2022 841,970 $ 109 1,681,225 (9,218) (830,146)
Ending balance, shares at Mar. 31, 2022   108,433,350      
Beginning balance at Dec. 31, 2021 897,808 $ 109 1,666,887 (1,088) (768,100)
Beginning balance, shares at Dec. 31, 2021   108,210,318      
Net Income (Loss) (138,834)        
Ending balance at Jun. 30, 2022 779,637 $ 109 1,698,368 (11,906) (906,934)
Ending balance, shares at Jun. 30, 2022   108,810,478      
Beginning balance at Mar. 31, 2022 841,970 $ 109 1,681,225 (9,218) (830,146)
Beginning balance, shares at Mar. 31, 2022   108,433,350      
Issuance of common stock upon exercise of stock options 859   859    
Issuance of common stock upon exercise of stock options, shares   182,113      
Issuance of common stock under ESPP 1,137   1,137    
Issuance of common stock under ESPP, shares   79,859      
Vesting of restricted stock units, Shares   115,156      
Stock compensation expense 15,147   15,147    
Unrealized loss on investments (2,688)     (2,688)  
Net Income (Loss) (76,788)       (76,788)
Ending balance at Jun. 30, 2022 779,637 $ 109 1,698,368 (11,906) (906,934)
Ending balance, shares at Jun. 30, 2022   108,810,478      
Beginning balance at Dec. 31, 2022 950,218 $ 121 2,019,126 (10,420) (1,058,609)
Beginning balance, shares at Dec. 31, 2022   121,112,234      
Issuance of common stock upon exercise of stock options 1,297   1,297    
Issuance of common stock upon exercise of stock options, shares   255,918      
Vesting of restricted stock units, Shares   108,506      
Stock compensation expense 21,518   21,518    
Unrealized loss on investments 4,618     4,618  
Net Income (Loss) (94,239)       (94,239)
Ending balance at Mar. 31, 2023 883,412 $ 121 2,041,941 (5,802) (1,152,848)
Ending balance, shares at Mar. 31, 2023   121,476,658      
Beginning balance at Dec. 31, 2022 950,218 $ 121 2,019,126 (10,420) (1,058,609)
Beginning balance, shares at Dec. 31, 2022   121,112,234      
Net Income (Loss) (192,744)        
Ending balance at Jun. 30, 2023 810,119 $ 122 2,067,431 (6,081) (1,251,353)
Ending balance, shares at Jun. 30, 2023   121,944,876      
Beginning balance at Mar. 31, 2023 883,412 $ 121 2,041,941 (5,802) (1,152,848)
Beginning balance, shares at Mar. 31, 2023   121,476,658      
Issuance of common stock upon exercise of stock options 453 $ 1 452    
Issuance of common stock upon exercise of stock options, shares   96,605      
Issuance of common stock under ESPP 1,627   1,627    
Issuance of common stock under ESPP, shares   152,369      
Vesting of restricted stock units, Shares   219,244      
Stock compensation expense 23,411   23,411    
Unrealized loss on investments (279)     (279)  
Net Income (Loss) (98,505)       (98,505)
Ending balance at Jun. 30, 2023 $ 810,119 $ 122 $ 2,067,431 $ (6,081) $ (1,251,353)
Ending balance, shares at Jun. 30, 2023   121,944,876